Jimmy Hwang


Ontology type: schema:Person     


Person Info

NAME

Jimmy

SURNAME

Hwang

Publications in SciGraph latest 50 shown

  • 2018-03 A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2017-08 Fertility preservation with ovarian stimulation and time to treatment in women with stage II–III breast cancer receiving neoadjuvant therapy in BREAST CANCER RESEARCH AND TREATMENT
  • 2017-08 Erratum to: Fertility preservation with ovarian stimulation and time to treatment in women with stage II–III breast cancer receiving neoadjuvant therapy in BREAST CANCER RESEARCH AND TREATMENT
  • 2017-02 The challenge of measuring intra-individual change in fatigue during cancer treatment in QUALITY OF LIFE RESEARCH
  • 2017-02 Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2016-11 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2015-12 Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls in BMC CANCER
  • 2015-04 The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial in BRITISH JOURNAL OF CANCER
  • 2015-04 Open-label phase 1b study of FOLFIRI plus cetuximab plus IMO-2055 in patients with colorectal cancer who have progressed following chemotherapy for advanced or metastatic disease in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2014-05 A phase I study of oral ixabepilone in patients with advanced solid tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2013-10 A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer in BRITISH JOURNAL OF CANCER
  • 2013-06 Decrease in blood miR-296 predicts chemotherapy resistance and poor clinical outcome in patients receiving systemic chemotherapy for metastatic colon cancer in INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
  • 2013-04 A Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors in INVESTIGATIONAL NEW DRUGS
  • 2013-03 Survivorship Clinic Group Educational Sessions: Adoption, Acceptance, and Attendance in JOURNAL OF CANCER EDUCATION
  • 2013-03 A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2012-12 A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2012-12 Phase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 3 weeks in patients with advanced solid tumors in INVESTIGATIONAL NEW DRUGS
  • 2012-08 The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivors in BREAST CANCER RESEARCH AND TREATMENT
  • 2012-03 The Impact of Primary Melanoma Thickness and Microscopic Tumor Burden in Sentinel Lymph Nodes on Melanoma Patient Survival in ANNALS OF SURGICAL ONCOLOGY
  • 2012-01 Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma in BRITISH JOURNAL OF CANCER
  • 2010-11 Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma in BRITISH JOURNAL OF CANCER
  • 2010-11 A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2010-03 Healthy Colon, Healthy Life (Colon Sano, Vida Sana): Colorectal Cancer Screening Among Latinos in Santa Clara, California in JOURNAL OF CANCER EDUCATION
  • 2009-12 Treatment of Metastatic Colorectal Cancer in the Elderly in CURRENT TREATMENT OPTIONS IN ONCOLOGY
  • 2009-03 Improving colorectal cancer screening: A partnership between primary care practices and the American Cancer Society in JOURNAL OF CANCER EDUCATION
  • 2008-10 A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable? in INVESTIGATIONAL NEW DRUGS
  • 2008-05 Candidate Diagnostic Markers and Tumor Suppressor Genes for Adrenocortical Carcinoma by Expression Profile of Genes on Chromosome 11q13 in WORLD JOURNAL OF SURGERY
  • 2007-03 Provider knowledge and practice regarding hepatitis B screening in Chinese-speaking patients in JOURNAL OF CANCER EDUCATION
  • 2006 Chemotherapy in Patients with Organ Dysfunction in ONCOLOGY
  • 2005-07 Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer in BRITISH JOURNAL OF CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.468189.a", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.189509.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410711.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240614.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.51462.34", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411663.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412530.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.94365.3d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.213910.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411024.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.478063.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.266102.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.241167.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.214572.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412332.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.266100.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411667.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.239494.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412584.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412578.d", 
            "type": "Organization"
          }
        ], 
        "familyName": "Hwang", 
        "givenName": "Jimmy", 
        "id": "sg:person.01004005752.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004005752.19"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T15:00", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_714.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01004005752.19'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01004005752.19'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01004005752.19'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01004005752.19'


     

    This table displays all metadata directly associated to this object as RDF triples.

    54 TRIPLES      10 PREDICATES      30 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01004005752.19 schema:affiliation N797287da6e7d4cb7a6d67ad77ff6d260
    2 https://www.grid.ac/institutes/grid.189509.c
    3 https://www.grid.ac/institutes/grid.213910.8
    4 https://www.grid.ac/institutes/grid.214572.7
    5 https://www.grid.ac/institutes/grid.239494.1
    6 https://www.grid.ac/institutes/grid.240614.5
    7 https://www.grid.ac/institutes/grid.241167.7
    8 https://www.grid.ac/institutes/grid.266100.3
    9 https://www.grid.ac/institutes/grid.266102.1
    10 https://www.grid.ac/institutes/grid.410711.2
    11 https://www.grid.ac/institutes/grid.411024.2
    12 https://www.grid.ac/institutes/grid.411663.7
    13 https://www.grid.ac/institutes/grid.411667.3
    14 https://www.grid.ac/institutes/grid.412332.5
    15 https://www.grid.ac/institutes/grid.412530.1
    16 https://www.grid.ac/institutes/grid.412578.d
    17 https://www.grid.ac/institutes/grid.412584.e
    18 https://www.grid.ac/institutes/grid.478063.e
    19 https://www.grid.ac/institutes/grid.51462.34
    20 https://www.grid.ac/institutes/grid.94365.3d
    21 schema:familyName Hwang
    22 schema:givenName Jimmy
    23 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004005752.19
    24 schema:sdDatePublished 2019-03-07T15:00
    25 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    26 schema:sdPublisher Nf879e4b59353422eaaf0f385e48daef2
    27 sgo:license sg:explorer/license/
    28 sgo:sdDataset persons
    29 rdf:type schema:Person
    30 N797287da6e7d4cb7a6d67ad77ff6d260 schema:affiliation https://www.grid.ac/institutes/grid.468189.a
    31 sgo:isCurrent true
    32 rdf:type schema:OrganizationRole
    33 Nf879e4b59353422eaaf0f385e48daef2 schema:name Springer Nature - SN SciGraph project
    34 rdf:type schema:Organization
    35 https://www.grid.ac/institutes/grid.189509.c schema:Organization
    36 https://www.grid.ac/institutes/grid.213910.8 schema:Organization
    37 https://www.grid.ac/institutes/grid.214572.7 schema:Organization
    38 https://www.grid.ac/institutes/grid.239494.1 schema:Organization
    39 https://www.grid.ac/institutes/grid.240614.5 schema:Organization
    40 https://www.grid.ac/institutes/grid.241167.7 schema:Organization
    41 https://www.grid.ac/institutes/grid.266100.3 schema:Organization
    42 https://www.grid.ac/institutes/grid.266102.1 schema:Organization
    43 https://www.grid.ac/institutes/grid.410711.2 schema:Organization
    44 https://www.grid.ac/institutes/grid.411024.2 schema:Organization
    45 https://www.grid.ac/institutes/grid.411663.7 schema:Organization
    46 https://www.grid.ac/institutes/grid.411667.3 schema:Organization
    47 https://www.grid.ac/institutes/grid.412332.5 schema:Organization
    48 https://www.grid.ac/institutes/grid.412530.1 schema:Organization
    49 https://www.grid.ac/institutes/grid.412578.d schema:Organization
    50 https://www.grid.ac/institutes/grid.412584.e schema:Organization
    51 https://www.grid.ac/institutes/grid.468189.a schema:Organization
    52 https://www.grid.ac/institutes/grid.478063.e schema:Organization
    53 https://www.grid.ac/institutes/grid.51462.34 schema:Organization
    54 https://www.grid.ac/institutes/grid.94365.3d schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...